Screener
Royalty Pharma RPRX Price / earnings
Price / earnings at other companies
Other financials
Where this comes from
Calculated from Royalty Pharma’s reported figures.
Based on the most recent quarter.
The source filing: Royalty Pharma’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 9:02 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001802768-26-000015
FAQ
- What is Royalty Pharma's price / earnings?
- Royalty Pharma (RPRX) reported price / earnings of 30.5× in Q2 2026.
- How has Royalty Pharma's price / earnings changed year-over-year?
- Royalty Pharma's price / earnings increased by 105.0% year-over-year, from 14.9× to 30.5×.
- What is the long-term trend for Royalty Pharma's price / earnings?
- Over 4 years (2020 to 2025), Royalty Pharma's price / earnings has grown at a 16.9% compound annual growth rate (CAGR), from 11.4× to 21.3×.
- What does price / earnings mean?
- Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.
Ask your AI about Royalty Pharma's price / earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude